A
Ana María Zarate
Researcher at National University of Cordoba
Publications - 15
Citations - 112
Ana María Zarate is an academic researcher from National University of Cordoba. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 4, co-authored 10 publications receiving 81 citations.
Papers
More filters
Journal ArticleDOI
Risk genes in head and neck cancer: A systematic review and meta-analysis of last 5 years
TL;DR: The aim of this work was to identify risk genes related to the development and progression of squamous cell carcinoma head and neck (SCCHN) and do a meta-analysis of available estimates, showing no significant association between different allelic variants of Arg72Pro rs1042522 and SCCHN risk.
Journal ArticleDOI
Exfoliative cytology as a tool for monitoring pre-malignant and malignant lesions based on combined stains and morphometry techniques
Ignacio Gonzalez Segura,Dante Gustavo Secchi,Andres Carrica,Rosario Barello,Dario Arbelo,Adriana Burgos,Mabel Brunotto,Ana María Zarate +7 more
TL;DR: The total number of AgNOR is a reliable marker for detecting neoplastic cells; this method increases sensitivity and specificity by decreasing the likelihood of false negatives or positives, as the accuracy obtained was 90%.
Journal ArticleDOI
Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients.
Ana María Zarate,Julieta Don,Dante Gustavo Secchi,Andres Carrica,Fernanda Galindez Costa,René Panico,Martín Brusa,José L. Barra,Mabel Brunotto +8 more
TL;DR: The results showed that the wild-type Arg72variant was related to control patients and Pro72Variant wasrelated to OC and OPMD, in Argentine patients.
Journal ArticleDOI
Graph models for phenotype and genotype association between oral mucosa and submandibular gland tumorigenesis in rat
TL;DR: Graph statistical model with one latent variable may be useful in detecting early changes in SMG tumorigenesis and the design of randomized sampling of oral mucosa allows to validate these results and establish a reliable methodology for presumptive diagnosis or screening in the future.
Journal ArticleDOI
New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
Christian Espinosa-Bustos,María Ortiz Pérez,Alonzo González-González,Ana María Zarate,Gildardo Rivera,Javier Alejandro Belmont-Díaz,Emma Saavedra,Mauricio Cuellar,Karina Arvizu Vazquez,Cristian O. Salas +9 more
TL;DR: The naphthoquinone nucleus should be considered in the search for new trypanocidal agents based on 7j, one of the compounds that showed the best interaction profile on the enzyme; therefore, 7j was evaluated on TR, which behaved as a non-competitive inhibitor.